Showing results (151-160 of 262) with videos related to
Sort By:
Pageof 27
Archives of Physical Medicine and Rehabilitation|August 18, 2021
Combining the AM-PAC "6-Clicks" and the Morse Fall Scale to Predict Individuals at Risk for Falls in an Inpatient Rehabilitation HospitalKeith R Lohse, Danica R Dummer, Heather A Hayes, et al.The British Journal of Dermatology|July 24, 2004
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipientsG Dragieva, B M Prinz, J Hafner, et al.Cancer Research|February 28, 2001
PAX3 is expressed in human melanomas and contributes to tumor cell survivalF A Scholl, J Kamarashev, O V Murmann, et al.Clinical and Experimental Dermatology|February 4, 2012
Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observationB M Prinz Vavricka, G F L Hofbauer, R Dummer, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 17, 2011
Changing pathology with changing drugs: skin cancerM B Karpova, M J Barysch, M C Zipser, et al.The American Journal of Pathology|February 1, 1997
No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphomaG S Wood, J M Schaffer, R Boni, et al.Dermatology (Basel, Switzerland)|January 1, 1995
Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanomaR Böni, R A Huch Böni, H Steinert, et al.Journal of Molecular Medicine (Berlin, Germany)|July 4, 2001
Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horsesL M Heinzerling, K Feige, S Rieder, et al.Experimental Dermatology|June 1, 1997
A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferationsJ C Meyer, S Hassam, R Dummer, et al.European Journal of Cancer (Oxford, England : 1990)|August 7, 2016
MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effectsU Urner-Bloch, M Urner, N Jaberg-Bentele, et al.Pageof 27